Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2005

01-01-2005 | Reviews

A panel discussion of controversies and challenges in the adjuvant treatment of colon cancer

Authors: Eduardo Díaz-Rubio García, Albert Abad Esteve, Antonio Antón Torres, Enrique Aranda Aguilar, Manuel Benavides Orgaz, Alfredo Carrato Mena, Andrés Cervantes Ruipérez, Jaime Feliu Batle, Pilar García Alfonso, Jesús García Foncillas, Cristina Garávalos Castro, Matilde Navarro García, Fernando Rivera Herrero, José María Tabernero Caturla

Published in: Clinical and Translational Oncology | Issue 1/2005

Login to get access
Metadata
Title
A panel discussion of controversies and challenges in the adjuvant treatment of colon cancer
Authors
Eduardo Díaz-Rubio García
Albert Abad Esteve
Antonio Antón Torres
Enrique Aranda Aguilar
Manuel Benavides Orgaz
Alfredo Carrato Mena
Andrés Cervantes Ruipérez
Jaime Feliu Batle
Pilar García Alfonso
Jesús García Foncillas
Cristina Garávalos Castro
Matilde Navarro García
Fernando Rivera Herrero
José María Tabernero Caturla
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 1/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710019

Other articles of this Issue 1/2005

Clinical and Translational Oncology 1/2005 Go to the issue

Case Reports

Subacute dementia as presenting feature of carcinomatous leptomeningeal metastases

Teaching Section

Rhabdomyosarcoma: present and future perspectives in diagnosis and treatment

Correspondence

Carta abierta a la sociedad española de oncología quirúrgica

Editorial

Prognostic factors in neuroblastoma: the need for evidencebased decisions in prospective studies

Original Articles

Prognostic factors including neoadjuvant chemotherapy in Mexican children with neuroblastoma

Original Articles

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits